Correspondence 0001193125-25-014351 from Metsera, Inc. (MTSR) (CIK 0002040807)
Metsera, Inc. (MTSR) (CIK 0002040807)
Date: Jan. 28, 2025 · CIK: 0002040807 · Accession: 0001193125-25-014351
AI Filing Summary & Sentiment
File numbers found in text: 333-284225
Show Raw Text
CORRESP 1 filename1.htm CORRESP Metsera, Inc. 3 World Trade Center 175 Greenwich Street New York, New York 10007 January 28, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Jason Drory Chris Edwards Tracie Mariner Lynn Dicker Re: Metsera, Inc. Registration Statement on Form S-1, as amended (File No. 333-284225) Request for Acceleration of Effective Date To the addressees set forth above: In accordance with Rule 461 under the Securities Act of 1933, as amended, Metsera, Inc. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-1 (File No. 333-284225) (as amended, the “Registration Statement”). The Company respectfully requests that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on January 30, 2025, or as soon as practicable thereafter, or at such other time as the Company or its legal counsel may request by telephone to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Ross McAloon at (714) 755-8051. Thank you for your assistance in this matter. [Signature page follows] Sincerely, Metsera, Inc. By: /s/ Christopher Whitten Bernard Name: Christopher Whitten Bernard Title: President and Chief Executive Officer cc: Christopher J. Visioli, Chief Financial Officer, Metsera, Inc. Peter N. Handrinos, Latham & Watkins LLP B. Shayne Kennedy, Latham & Watkins LLP J. Ross McAloon, Latham & Watkins LLP Rachael Bushey, Goodwin Procter LLP Williams D. Collins, Goodwin Procter LLP Adam V. Johnson, Goodwin Procter LLP